HOME >> BIOLOGY >> NEWS
Intrakine blockade of a chemokine receptor

In one clever but still unproved scheme for blocking the progression of AIDS, a so-called "intrakine" is to be transduced into lymphocytes to prevent surface expression of a molecule required for HIV entry. Infection by HIV depends in part on the surface protein CXCR4, a receptor whose endogenous ligand is the chemokine SDF-1. Earlier work showed that an engineered SDF-1 variant that is retained in the endoplasmic reticulum has a dominant effect on CXCR4, preventing the receptor from reaching the cell surface and thus rendering the cell resistant to HIV. Clinical tests of this approach are ongoing, but meanwhile Zeelenberg and colleagues have used the same system to examine other cellular effects of loss of CXCR4 surface expression. They show here that T lemphocyte-derived hybridomas--usually an invasive cell type that can cross multiple barriers to reach target organs-- lose their ability to migrate in response to SDF-1. These transfected hybridomas fail to cross cell monolayers in culture or to exit the bloodstream when introduced in vivo. A control intrakine that blocks surface expression of a different chemokine receptor, CCR4, does not affect the ability of these cells to disseminate or generate malignant tumors, indicating that SDF-1 signaling is specifically required for invasive behavior by these cells. Whether normal T cells also depend on the SDF-1/CXCR4 interaction to reach their target tissues is not clear, but if so, the SDF-1 intrakine strategy for treating AIDS may prove to be immunosuppressive in its own right.


'"/>

Contact: John Ashkenas
scied@the-jci.org
416-946-7593
Journal of Clinical Investigation
11-Jul-2001


Page: 1

Related biology news :

1. Ovarian cancer sheds tumor suppression with loss of estrogen receptor
2. Alterations in vitamin D receptor gene increase prostate, breast cancer risk
3. Two-pronged attack targeting EGF receptor hinders cancer cell growth
4. Tamoxifen stimulates breast cancer growth following alteration of estrogen receptor
5. Dioxin-receptor network identified
6. Inhibition of insulin-like growth factor receptor-1 as promising anticancer therapeutic
7. Scientists at Scripps Research Institute describe structure of receptor on surface of 1918 flu virus
8. Activation of receptor ups development of precancerous intestinal polyps
9. Researchers find an association between alcohol dependence and the GABAA receptor gene GABRG3
10. The dopamine receptor D1 gene and ADHD: A piece of the genetic puzzle?
11. Estrogen receptor-a disruption and vasodilation in coronary arteries

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... July 09, 2020 , ... Today CJ BIO announced ... will share insight on the “fifth taste” phenomenon that is revolutionizing ingredient mixes, nutritional ... Advantage will be live on Monday, July 13, 2020 at11:00 AM (CDT) during SHIFT20, ...
(Date:7/2/2020)... ... July 02, 2020 , ... ... detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for ... minutes. The article, titled "Ultra-fast one-step RT-PCR protocol for the detection of ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... software solutions for biopharmaceutical R&D, today announced that it has entered into ... full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy ...
Breaking Biology News(10 mins):
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
(Date:7/18/2020)... (PRWEB) , ... July 17, 2020 , ... ... global consulting firm for the life sciences and food industries, is pleased to ... Director of Clinical Research – Business Development. , Charles is an accomplished and ...
(Date:7/10/2020)... (PRWEB) , ... July 09, 2020 , ... ... to cell therapy, today announced the hiring of Allen R. Nissenson, M.D., F.A.C.P., ... and oversee the clinical development of Sentien’s lead product, SBI-101. Dr. Nissenson ...
(Date:7/1/2020)... ... June 29, 2020 , ... ... procured purchasing contracts to its membership, recently named BioFit Engineered Products ... the opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at ...
Breaking Biology Technology:
Cached News: